News & Updates

Show Multimedia Only

VIDEO: Real-world and clinical trial data on apalutamide in mHSPC

26 Jun 2025 by

Dr Darren Poon, Specialist in Clinical Oncology at Hong Kong Sanatorium & Hospital and Honorary Clinical Associate Professor at the Chinese University of Hong Kong, shares key insights from TITAN and OASIS studies and highlights the association between PSA response and survival outcomes.

VIDEO: Real-world and clinical trial data on apalutamide in mHSPC

26 Jun 2025

Ultrasonic propulsion clears residual stone fragments in kidney

24 Jun 2025 by

More patients who underwent ultrasonic propulsion (UP), facilitated by an independent group of operators, benefit from the passage of residual kidney stone fragments and from a decreased stone burden than those who did not receive treatment, a recent trial has shown.

Ultrasonic propulsion clears residual stone fragments in kidney

24 Jun 2025

IgAN drug hits target in phase III study

23 Jun 2025 by

The selective immunoglobulin (Ig)G2 antibody sibeprenlimab reduces proteinuria in individuals with IgA nephropathy (IgAN) in an interim analysis of the phase III VISIONARY study.

IgAN drug hits target in phase III study

23 Jun 2025

Cabozantinib plus atezolizumab improves PFS in mCRPC after progression on ARPI

20 Jun 2025

In the treatment of patients with metastatic castration-resistant prostate cancer (mCRPC) with extrapelvic soft-tissue metastases that has progressed on an androgen receptor pathway inhibitor (ARPI), the combination of cabozantinib plus atezolizumab appears to prolong progression-free survival (PFS), according to data from the open-label phase 3 CONTACT-02 trial.

Cabozantinib plus atezolizumab improves PFS in mCRPC after progression on ARPI

20 Jun 2025

Glucose-lowering med shows promise for treating kidney stones in nondiabetics

17 Jun 2025 by

Treatment with the sodium-glucose cotransporter 2 (SGLT2) inhibitor empagliflozin helps improve the urinary lithogenic risk profile of nondiabetic patients with calcium and uric acid stones, as shown in the results of the randomized crossover SWEETSTONE trial.

Glucose-lowering med shows promise for treating kidney stones in nondiabetics

17 Jun 2025

Low-carb, animal fat/protein-heavy diet poses increased bladder cancer risk

12 Jun 2025 by

A low-carbohydrate diet (LCD), particularly when its fat and protein sources are predominantly animal-based, may contribute to increased risk of bladder cancer among Chinese Singaporeans, according to new research.

Low-carb, animal fat/protein-heavy diet poses increased bladder cancer risk

12 Jun 2025

Differences in pelvic floor anatomy may explain UI in female athletes

08 Jun 2025

Urinary incontinence in nulliparous female elite athletes may have multifactorial aetiology, as shown by differences seen in dynamic pelvic MRI, reports a study.

Differences in pelvic floor anatomy may explain UI in female athletes

08 Jun 2025

Mind over bladder: Mindfulness, zap therapy help with situational urge incontinence

07 Jun 2025 by

Noninvasive approaches such as mindfulness training and transcranial direct current stimulation (tDCS) hold therapeutic potential in women with situational urgency urinary incontinence (UUI), as shown in a study.

Mind over bladder: Mindfulness, zap therapy help with situational urge incontinence

07 Jun 2025

Gemcitabine for IR-NMIBC tied to more recurrence vs BCG

06 Jun 2025 by

Treatment-naive patients with immediate-risk (IR) nonmuscle-invasive bladder cancer (NMIBC) who received gemcitabine appear to have greater recurrence risk than those given Bacillus Calmette-Guerin (BCG). Both treatments, however, are effective against disease progression.

Gemcitabine for IR-NMIBC tied to more recurrence vs BCG

06 Jun 2025

VIDEO: Apalutamide’s tolerability in prostate cancer patients

19 May 2025 by

Dr Darren Poon, Specialist in Clinical Oncology at Hong Kong Sanatorium & Hospital and Honorary Clinical Associate Professor at the Chinese University of Hong Kong, discusses apalutamide’s tolerability in prostate cancer patients.

VIDEO: Apalutamide’s tolerability in prostate cancer patients

19 May 2025

News & Updates

Filter by Specialty:

Specialty:

VIDEO: Real-world and clinical trial data on apalutamide in mHSPC

VIDEO: Real-world and clinical trial data on apalutamide in mHSPC

Ultrasonic propulsion clears residual stone fragments in kidney

Ultrasonic propulsion clears residual stone fragments in kidney

IgAN drug hits target in phase III study

IgAN drug hits target in phase III study

Cabozantinib plus atezolizumab improves PFS in mCRPC after progression on ARPI

Cabozantinib plus atezolizumab improves PFS in mCRPC after progression on ARPI

Glucose-lowering med shows promise for treating kidney stones in nondiabetics

Glucose-lowering med shows promise for treating kidney stones in nondiabetics

Low-carb, animal fat/protein-heavy diet poses increased bladder cancer risk

Low-carb, animal fat/protein-heavy diet poses increased bladder cancer risk

Differences in pelvic floor anatomy may explain UI in female athletes

Differences in pelvic floor anatomy may explain UI in female athletes

Mind over bladder: Mindfulness, zap therapy help with situational urge incontinence

Mind over bladder: Mindfulness, zap therapy help with situational urge incontinence

Gemcitabine for IR-NMIBC tied to more recurrence vs BCG

Gemcitabine for IR-NMIBC tied to more recurrence vs BCG

VIDEO: Apalutamide’s tolerability in prostate cancer patients

VIDEO: Apalutamide’s tolerability in prostate cancer patients